204 related articles for article (PubMed ID: 28267463)
1. Early inpatient calculation of laboratory-based 30-day readmission risk scores empowers clinical risk modification during index hospitalization.
Horne BD; Budge D; Masica AL; Savitz LA; Benuzillo J; Cantu G; Bradshaw A; McCubrey RO; Bair TL; Roberts CA; Rasmusson KD; Alharethi R; Kfoury AG; James BC; Lappé DL
Am Heart J; 2017 Mar; 185():101-109. PubMed ID: 28267463
[TBL] [Abstract][Full Text] [Related]
2. Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
Staszewsky L; Cortesi L; Tettamanti M; Dal Bo GA; Fortino I; Bortolotti A; Merlino L; Latini R; Roncaglioni MC; Baviera M
Eur J Heart Fail; 2016 Jul; 18(7):840-8. PubMed ID: 27098360
[TBL] [Abstract][Full Text] [Related]
3. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
[TBL] [Abstract][Full Text] [Related]
4. Risk Stratification Model for 30-Day Heart Failure Readmission in a Multiethnic South East Asian Community.
Leong KT; Wong LY; Aung KC; Macdonald M; Cao Y; Lee S; Chow WL; Doddamani S; Richards AM
Am J Cardiol; 2017 May; 119(9):1428-1432. PubMed ID: 28302271
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
Berger R; Moertl D; Peter S; Ahmadi R; Huelsmann M; Yamuti S; Wagner B; Pacher R
J Am Coll Cardiol; 2010 Feb; 55(7):645-53. PubMed ID: 20170790
[TBL] [Abstract][Full Text] [Related]
6. Risk prediction for 30-day heart failure-specific readmission or death after discharge: Data from the Korean Acute Heart Failure (KorAHF) registry.
Lim NK; Lee SE; Lee HY; Cho HJ; Choe WS; Kim H; Choi JO; Jeon ES; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Oh BH; Park HY
J Cardiol; 2019 Feb; 73(2):108-113. PubMed ID: 30360893
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
[TBL] [Abstract][Full Text] [Related]
8. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary-Specific Intermountain Risk Score Predicts All-Cause Mortality via Spirometry, the Red Cell Distribution Width, and Other Laboratory Parameters.
Horne BD; Hegewald M; Muhlestein JB; May HT; Huggins EJ; Bair TL; Anderson JL
Respir Care; 2015 Sep; 60(9):1314-23. PubMed ID: 25873741
[TBL] [Abstract][Full Text] [Related]
10. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
[TBL] [Abstract][Full Text] [Related]
11. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with 30-day readmission of patients with heart failure from a Japanese administrative database.
Aizawa H; Imai S; Fushimi K
BMC Cardiovasc Disord; 2015 Oct; 15():134. PubMed ID: 26497394
[TBL] [Abstract][Full Text] [Related]
13. Current medical therapy for advanced heart failure.
Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
Am Heart J; 1998 Jun; 135(6 Pt 2 Su):S231-48. PubMed ID: 9630088
[No Abstract] [Full Text] [Related]
14. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
[TBL] [Abstract][Full Text] [Related]
15. Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials.
Vader JM; LaRue SJ; Stevens SR; Mentz RJ; DeVore AD; Lala A; Groarke JD; AbouEzzeddine OF; Dunlay SM; Grodin JL; Dávila-Román VG; de Las Fuentes L
J Card Fail; 2016 Nov; 22(11):875-883. PubMed ID: 27133201
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
[TBL] [Abstract][Full Text] [Related]
18. Four-variable risk model in men and women with heart failure.
Chyu J; Fonarow GC; Tseng CH; Horwich TB
Circ Heart Fail; 2014 Jan; 7(1):88-95. PubMed ID: 24281135
[TBL] [Abstract][Full Text] [Related]
19. Burden and Causes of Hospital Admissions in Heart Failure During the Last Year of Life.
Madelaire C; Gustafsson F; Kristensen SL; D'Souza M; Stevenson LW; Kober L; Torp-Pedersen C; Gislason G; Schou M
JACC Heart Fail; 2019 Jul; 7(7):561-570. PubMed ID: 31248567
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF.
Sanders-van Wijk S; Muzzarelli S; Neuhaus M; Kiencke S; Maeder M; Estlinbaum W; Tobler D; Mayer K; Erne P; Pfisterer ME; Brunner-La Rocca HP;
Eur J Heart Fail; 2013 Aug; 15(8):910-8. PubMed ID: 23666681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
